Finance

Lists
001630:KRX
Chongkundang Holdings Corp
â‚©38,950.00
+0.13%
(+50.00) 1D
Sep 4, 12:41:16 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001630...
Open
â‚©39,300
High
â‚©39,500
Low
â‚©38,900
Mkt. cap
195.13B
Avg. vol.
3.91K
Volume
70.00
Dividend
3.59%
Quarterly dividend
â‚©350
Ex-dividend date
Mar 30, 2026
P/E ratio
3.97
52-wk high
â‚©55,600
52-wk low
â‚©36,000
EPS
â‚©9,818
Shares outstanding
5.01M
No. of employees
34
Open
â‚©39,300
High
â‚©39,500
Low
â‚©38,900
Mkt. cap
195.13B
Avg. vol.
3.91K
Volume
70.00
Dividend
3.59%
Quarterly dividend
â‚©350
Ex-dividend date
Mar 30, 2026
P/E ratio
3.97
52-wk high
â‚©55,600
52-wk low
â‚©36,000
EPS
â‚©9,818
Shares outstanding
5.01M
No. of employees
34
About Chongkundang Holdings Corp
CEO-
Employees34
FoundedMay 7, 1941
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
234.22B
235.99B
240.27B
251.17B
Cost of goods sold
129.67B
138.25B
128.74B
147.84B
Cost of revenue
129.67B
138.25B
128.74B
147.84B
Research and development expenses
6.64B
8.34B
8.66B
8.59B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75.78B
71.50B
80.05B
84.37B
Operating expense
86.44B
86.63B
92.37B
96.67B
Total operating expenses
216.11B
224.88B
221.11B
244.51B
Operating income
18.11B
11.11B
19.16B
6.66B
Other non operating income
3.26B
-427.38M
-220.68M
-1.13B
EBT including unusual items
28.73B
13.05B
20.56B
26.47B
EBT excluding unusual items
17.32B
6.55B
15.31B
1.53B
Income tax expense
8.68B
-2.02B
2.66B
8.83B
Effective tax rate
30.22%
-15.51%
12.95%
33.36%
Other operating expenses
1.09B
1.68B
582.81M
608.63M
Net income
13.40B
10.53B
12.89B
16.85B
Net profit margin
5.72%
4.46%
5.36%
6.71%
Earnings per share
-
-
-
-
Interest and investment income
200.59M
484.17M
222.40M
501.70M
Interest expense
-5.10B
-5.27B
-5.32B
-5.47B
Net interest expenses
-4.90B
-4.78B
-5.10B
-4.97B
Depreciation and amortization charges
2.06B
1.66B
2.00B
2.05B
EBITDA
29.14B
22.57B
30.37B
18.23B
Gain or loss from assets sale
-9.93M
-924.00K
381.06M
-482.36M
AI content may include mistakes. Learn more
Google apps